Literature DB >> 10229798

Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation.

D A Mitchell1, P R Taylor, H T Cook, J Moss, A E Bygrave, M J Walport, M Botto.   

Abstract

C1q-deficient (C1qa-/-) mice develop antinuclear Abs and glomerulonephritis (GN) characterized by multiple apoptotic bodies. To explore the contribution of C3 activation to the induction of spontaneous GN, C1qa-/- mice were crossed with factor B- and C2-deficient (H2-Bf/C2-/-) mice. GN was present in 64% of the 45 C1qa/H2-Bf/C2-/- mice compared with 8% of the 65 H2-Bf/C2-/- mice and none of the 24 wild-type controls. IgG was detected in the glomeruli of diseased C1qa/H2-Bf/C2-/- kidneys. However, glomerular staining for C3 was absent. Increased numbers of glomerular apoptotic bodies were detected in undiseased C1qa/H2-Bf/C2-/- kidneys. These findings support the hypothesis that C1q may play a role in the clearance of apoptotic cells without the necessity for C3 activation and demonstrate that the activation of C3 is not essential for the development of GN in this spontaneous model of lupus-like disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229798

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.

Authors:  Liudmila Kulik; Jennifer Laskowski; Brandon Renner; Rachel Woolaver; Lian Zhang; Taras Lyubchenko; Zhiying You; Joshua M Thurman; V Michael Holers
Journal:  J Immunol       Date:  2019-11-15       Impact factor: 5.422

Review 2.  Apoptosis and autoimmunity: complement deficiency and systemic lupus erythematosus revisited.

Authors:  J S Navratil; J M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

3.  Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.

Authors:  M Bijl; E Reefman; G Horst; P C Limburg; C G M Kallenberg
Journal:  Ann Rheum Dis       Date:  2005-05-26       Impact factor: 19.103

4.  Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.

Authors:  Jun Zhou; Maria I Fonseca; Karntipa Pisalyaput; Andrea J Tenner
Journal:  J Neurochem       Date:  2008-07-09       Impact factor: 5.372

5.  Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.

Authors:  V Michael Holers
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

6.  IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells.

Authors:  Yifang Chen; Yong-Beom Park; Ekta Patel; Gregg J Silverman
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

7.  A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.

Authors:  P R Taylor; A Carugati; V A Fadok; H T Cook; M Andrews; M C Carroll; J S Savill; P M Henson; M Botto; M J Walport
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

8.  Anti-C1q antibodies and their association with complement components in Indian systemic lupus erythematosus patients.

Authors:  V Pradhan; A Rajadhyaksha; G Mahant; P Surve; M Patwardhan; S Dighe; K Ghosh
Journal:  Indian J Nephrol       Date:  2012-09

9.  NETs: the missing link between cell death and systemic autoimmune diseases?

Authors:  Erika Darrah; Felipe Andrade
Journal:  Front Immunol       Date:  2013-01-17       Impact factor: 7.561

Review 10.  Complement and systemic lupus erythematosus.

Authors:  Mark J Walport
Journal:  Arthritis Res       Date:  2002-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.